- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
- RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
- RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
- RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
- RxSight, Inc. Reports Third Quarter 2023 Financial Results
- RxSight, Inc. Educational and Product Announcements for AAO 2023
More ▼
Key statistics
On Thursday, Rxsight Inc (RXST:NMQ) closed at 51.89, -10.86% below its 52-week high of 58.21, set on Mar 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 51.84 |
---|---|
High | 52.17 |
Low | 50.42 |
Bid | 50.02 |
Offer | 54.10 |
Previous close | 52.84 |
Average volume | 307.97k |
---|---|
Shares outstanding | 36.99m |
Free float | 30.17m |
P/E (TTM) | -- |
Market cap | 1.95bn USD |
EPS (TTM) | -1.42 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼